عنوان جدید
High-Growth Two-Location Medical Oncology Practice | Southwestern U.S. | Infusion & In-House Pharmacy
Seller Overview:
Seller States: This offering represents the opportunity to acquire a well-established, high-growth medical oncology practice with two locations in separate Southwestern states, each serving a distinct patient population. The primary location has operated for approximately 18 years and includes an in-house pharmacy, infusion suite, and Lab-corp, while the second location was established approximately four years ago to expand into an additional market.
Both offices are fully staffed and operate five days per week, with Nurse Practitioners, Physician Assistants, and Medical Assistants ensuring continuity of care and an uninterrupted service. The practice also maintains an experienced in-house billing team.
The seller, the sole oncologist, currently maintains a progressive clinical schedule across both locations. Significant growth opportunities exist through the future addition of provider, expanded clinic hours, and increased infusion and pharmacy volume.
Revenue is primarily derived from infusion services (~80%), including chemotherapy, and specialty pharmacy with approximately 14% generated from Evaluation & Management visits. Additional revenue streams include in-office procedures such as bone marrow biopsies. The in-house pharmacy operates at both primary locations (inventory not included in the sale).
The practice participates with Medicare and most major commercial insurers, providing a diversified and stable reimbursement base.
Growth Opportunities:
• Expand clinical capacity through additional physicians and/or APPs
• Increase infusion utilization and in-house pharmacy revenue
• Further penetrate two distinct and underserved regional markets
• Addition of imaging services and radiation therapy
Operations & Transition:
• Tenured, experienced clinical and administrative teams in place at both locations
• Established referral relationships and strong reputations in each community
• Efficient, scalable workflows to support a seamless ownership transition
• Seller available for 1–2 years to assist with transition, payer relationships, and growth initiatives
Services Provided:
• Medical oncology
• Hematology
• Chemotherapy and specialty infusions
• Immunotherapy
• Bone marrow biopsies
• Evaluation & Management (E&M) services
• Clinical research (included in this transaction) has increased from four (4) studies in 2025 to eleven (11) in 2026.
Investment Highlights:
• 2025 Gross Revenue of $19M+ with $2.17M+/- SDE & $1.62M+/-Adjusted EBITDA. 2026 is trending substantially higher than 2025.
• Two fully operational, modern facilities in separate Southwestern states
• High-margin, infusion-driven revenue model with ancillary pharmacy income
• Fully staffed, turnkey platform with capacity for provider expansion
• Significant upside through adding a full-time oncologist, expanding clinic hours, and increasing infusion and pharmacy volume
Additional Information:
Serious inquiries only. This medical practice operates in a regulated industry. Prospective buyers should have relevant industry experience and understand the applicable licensing and regulatory requirements.
Execution of a Non-Disclosure Agreement (NDA) and proof of funds are required prior to the release of confidential information.
One Southwest practice location is represented by First Choice Business Brokers Phoenix #213 #101, Dr. Fernando Acosta, Owner/Business Broker/Agent (AZ R.E. Lic.# LC68988001 | SA691260000) and Dr. Leilani Felix- Acosta, Owner/Business Broker (AZ R.E. Lic. #LC68988001 | SA693611000. The other Southwest practice location is represented by a separate licensed brokerage in that state.
شماره فهرست:
دسته:
مکان:
اطلاعات مالی:
درآمد ناخالص:
قیمت درج شده:
پیش پرداخت:
کل درآمد:
سال تاسیس:
اطلاعات اجاره:
فوت مربع:
مجموع اجاره:
انقضای اجاره نامه:
گزینه های اجاره:
اطلاعات دارایی:
بهبود اجاره نامه:
تجهیزات/لوازم:
موجودی:
سایر دارایی ها:
اطلاعات تکمیلی:
کارمندان تمام وقت:
کارمندان پاره وقت:
مجوز ویژه مورد نیاز:
کار قراردادی:
دوره آموزش:
دلیل فروش:
Hello World
کارگزاران کسب و کار انتخاب اول
اطلاعات موجود در اینجا از فروشنده دریافت شده است و قابل اعتماد است اما تضمین نمی شود. First Choice Business Brokers (FCBB)، برای ارائه جزئیات فوق به فروشنده متکی بوده و این اطلاعات را تأیید نکرده است. FCBB مسئولیتی در قبال اظهارات، پیش بینی ها یا اطلاعات ارائه شده توسط فروشنده ندارد و تضمین نمی کند. کاربر/خریدار تنها مسئول تأیید سود و عملیات تجاری فروشنده خواهد بود. با پذیرش این سند، خریدار/کاربر موافقت می کند که تمام اطلاعات مندرج در اینجا کاملاً محرمانه است و بدون مجوز کتبی قبلی به هیچ طرف دیگری فاش نخواهد شد. خریدار/کاربر تأیید میکند و میداند که FCBB تحقیق مستقلی درباره کسبوکار یا ارقام ذکر شده در اینجا انجام نداده است. هرگونه تغییر در اطلاعات فوق مستلزم تایید کتبی فروشنده و FCBB است. هرگونه تغییری که بدون تأیید FCBB و فروشنده در این سند ایجاد شود معتبر نیست.
اطلاعات این فهرست توسط فروشنده یا نماینده کسب و کار ذکر شده در بالا ارائه شده است. کارگزار کسب و کار First Choice هیچ سهمی در فروش این تجارت ندارد، هیچ یک از اطلاعات مربوط به کسب و کار را به طور مستقل تأیید نکرده است و هیچ مسئولیتی در قبال صحت یا کامل بودن آن بر عهده نمی گیرد.
قبل از پاسخ دادن به هر تبلیغی، شرایط استفاده، Broker Business Choice را بخوانید.
با کلیک بر روی دکمه، با شرایط استفاده و اطلاعیه حریم خصوصی کارگزاری First Choice موافقت می کنید
مشاهده سایر لیست ها
شماره فهرست:
دسته:
مکان:
قیمت درج شده:

High-Growth Two-Location Medical Oncology Practice | Southwestern U.S. | Infusion & In-House Pharmacy
Seller Overview:
Seller States: This offering represents the opportunity to acquire a well-established, high-growth medical oncology practice with two locations in separate Southwestern states, each serving a distinct patient population. The primary location has operated for approximately 18 years and includes an in-house pharmacy, infusion suite, and Lab-corp, while the second location was established approximately four years ago to expand into an additional market.
Both offices are fully staffed and operate five days per week, with Nurse Practitioners, Physician Assistants, and Medical Assistants ensuring continuity of care and an uninterrupted service. The practice also maintains an experienced in-house billing team.
The seller, the sole oncologist, currently maintains a progressive clinical schedule across both locations. Significant growth opportunities exist through the future addition of provider, expanded clinic hours, and increased infusion and pharmacy volume.
Revenue is primarily derived from infusion services (~80%), including chemotherapy, and specialty pharmacy with approximately 14% generated from Evaluation & Management visits. Additional revenue streams include in-office procedures such as bone marrow biopsies. The in-house pharmacy operates at both primary locations (inventory not included in the sale).
The practice participates with Medicare and most major commercial insurers, providing a diversified and stable reimbursement base.
Growth Opportunities:
• Expand clinical capacity through additional physicians and/or APPs
• Increase infusion utilization and in-house pharmacy revenue
• Further penetrate two distinct and underserved regional markets
• Addition of imaging services and radiation therapy
Operations & Transition:
• Tenured, experienced clinical and administrative teams in place at both locations
• Established referral relationships and strong reputations in each community
• Efficient, scalable workflows to support a seamless ownership transition
• Seller available for 1–2 years to assist with transition, payer relationships, and growth initiatives
Services Provided:
• Medical oncology
• Hematology
• Chemotherapy and specialty infusions
• Immunotherapy
• Bone marrow biopsies
• Evaluation & Management (E&M) services
• Clinical research (included in this transaction) has increased from four (4) studies in 2025 to eleven (11) in 2026.
Investment Highlights:
• 2025 Gross Revenue of $19M+ with $2.17M+/- SDE & $1.62M+/-Adjusted EBITDA. 2026 is trending substantially higher than 2025.
• Two fully operational, modern facilities in separate Southwestern states
• High-margin, infusion-driven revenue model with ancillary pharmacy income
• Fully staffed, turnkey platform with capacity for provider expansion
• Significant upside through adding a full-time oncologist, expanding clinic hours, and increasing infusion and pharmacy volume
Additional Information:
Serious inquiries only. This medical practice operates in a regulated industry. Prospective buyers should have relevant industry experience and understand the applicable licensing and regulatory requirements.
Execution of a Non-Disclosure Agreement (NDA) and proof of funds are required prior to the release of confidential information.
One Southwest practice location is represented by First Choice Business Brokers Phoenix #213 #101, Dr. Fernando Acosta, Owner/Business Broker/Agent (AZ R.E. Lic.# LC68988001 | SA691260000) and Dr. Leilani Felix- Acosta, Owner/Business Broker (AZ R.E. Lic. #LC68988001 | SA693611000. The other Southwest practice location is represented by a separate licensed brokerage in that state.
اطلاعات مالی
درآمد ناخالص:
قیمت درج شده:
پیش پرداخت:
کل درآمد:
سال تاسیس:
اطلاعات اجاره
فوت مربع:
مجموع اجاره:
انقضای اجاره نامه:
گزینه های اجاره:
اطلاعات دارایی
بهبود اجاره نامه:
تجهیزات/لوازم:
موجودی:
سایر دارایی ها:
اطلاعات تکمیلی
کارمندان تمام وقت:
کارمندان پاره وقت:
مجوز ویژه مورد نیاز:
کارکنان قراردادی:
دوره آموزش:
دلیل فروش:
کارگزاران کسب و کار انتخاب اول
اطلاعات موجود در اینجا از فروشنده دریافت شده است و قابل اعتماد است اما تضمین نمی شود. First Choice Business Brokers (FCBB)، برای ارائه جزئیات فوق به فروشنده متکی بوده و این اطلاعات را تأیید نکرده است. FCBB مسئولیتی در قبال اظهارات، پیش بینی ها یا اطلاعات ارائه شده توسط فروشنده ندارد و تضمین نمی کند. کاربر/خریدار تنها مسئول تأیید سود و عملیات تجاری فروشنده خواهد بود. با پذیرش این سند، خریدار/کاربر موافقت می کند که تمام اطلاعات مندرج در اینجا کاملاً محرمانه است و بدون مجوز کتبی قبلی به هیچ طرف دیگری فاش نخواهد شد. خریدار/کاربر تأیید میکند و میداند که FCBB تحقیق مستقلی درباره کسبوکار یا ارقام ذکر شده در اینجا انجام نداده است. هرگونه تغییر در اطلاعات فوق مستلزم تایید کتبی فروشنده و FCBB است. هرگونه تغییری که بدون تأیید FCBB و فروشنده در این سند ایجاد شود معتبر نیست.
اطلاعات این فهرست توسط فروشنده یا نماینده کسب و کار ذکر شده در بالا ارائه شده است. کارگزار کسب و کار First Choice هیچ سهمی در فروش این تجارت ندارد، هیچ یک از اطلاعات مربوط به کسب و کار را به طور مستقل تأیید نکرده است و هیچ مسئولیتی در قبال صحت یا کامل بودن آن بر عهده نمی گیرد.
قبل از پاسخ دادن به هر تبلیغی، شرایط استفاده، Broker Business Choice را بخوانید.